NCT00136110View on ClinicalTrials.gov

Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis

PHASE3CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

February 28, 2007

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG

Sodium Valproate

Trial Locations (1)

3584 CX

UMC Utrecht, Utrecht

All Listed Sponsors
collaborator

Princess Beatrix Muscle Foundation

OTHER

lead

UMC Utrecht

OTHER

NCT00136110 - Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter